Embedded LLM Launches the EU AI Grid at Munich Cyber Security Conference (MCSC) to Meet EU Demand for Sovereign AI Capability 
Deveron Completes Transaction to Sell Its Assets AdvanSix Announces Fourth Quarter and Full Year 2020 Financial Results
Strong volume growth, margin improvement and cash flow generation 4Q20 Sales of $340 million, up…
GlobeX Data CEO Interviewed on Proactive to Announce its Latest Distribution Deal to Bring its Sekur Platform to Australia
TORONTO, ON / ACCESSWIRE / February 19, 2021 / GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS) (FRA:…
Global Giveaway Of Special Edition Tesla Roadster Launched By Bitcoin Latinum
PALO ALTO, CA / ACCESSWIRE / February 19, 2021 / Bitcoin Latinum, the next generation…
Commerce Resources Corp. Announces Resumption of Trading Today on the OTCQX under the Symbol “CMRZF”
VANCOUVER, BC / ACCESSWIRE / February 19, 2021 / Commerce Resources Corp. (TSXV:CCE)(FSE:D7H0)(OTCQX:CMRZF) (the “Company”…
Geely and Concordium Announce a Joint Venture to Provide Blockchain Technology and Service in China Backed by Concordium’s Blockchain Technology
The Joint Venture will allow Geely and Concordium to offer businesses and customers access to…
UKCloud appoints Suhail Al Ansari, Co-Founder of Gawah Holdings Inc, to the position of Board Advisor for the Middle East & Africa
UKCloud has today announced the appointment of Suhail Al Ansari to advise its Board and…
Results of Placing – EUR 27 million Raised to Invest Further in US Launch and Commercialization Activities
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7…
DBV Technologies to Participate in SVB Leerink Global Partners Healthcare Conference
Montrouge, France, February 19, 2021 DBV Technologies to Participate in SVB Leerink Global Partners Healthcare…
Olainfarm expands presence in Ukraine to be closer to the clients
Olainfarm expanded its marketing team and updated its business model, setting up a fully operating…
Vistin Pharma ASA: Fourth quarter and preliminary 2020 financial results
Oslo, Norway, 19th of February 2021 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces…
Immunicum AB (publ) Receives Orphan Drug Designation from EMA for Ilixadencel as Treatment for Gastrointestinal Stromal Tumors (GIST)
Press Release 19 February 2021 Immunicum AB (publ) Receives Orphan Drug Designation from EMA for…
Travere Therapeutics Announces European Commission Has Granted Orphan Designation to Sparsentan for the Treatment of IgA Nephropathy
SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
HOLLISTON, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce…
Junshi Biosciences Announces Acceptance by the NMPA of Supplemental New Drug Application for Toripalimab Combined with Chemotherapy for The First-Line Treatment of Nasopharyngeal Carcinoma
–the 3rd sNDA for Toripalimab in China SHANGHAI, China, Feb. 19, 2021 (GLOBE NEWSWIRE) —…
MacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference Call
ROCKVILLE, MD, Feb. 18, 2021 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical…
Osmotica to Present at 10th Annual SVB Leerink Global Healthcare Conference
BRIDGEWATER, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or…
Codexis to Present at Upcoming Virtual Healthcare Conferences
REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme…
Apellis Pharmaceuticals to Hold Fourth Quarter and Full Year 2020 Earnings Conference Call on February 25, 2021
WALTHAM, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…
Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key Enterprise Functions, Transformation and Growth Initiatives
New talent and promotions span core businesses, transformation, IT, revenue cycle management, business development, marketing,…
Diffusion Pharmaceuticals Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares of Common Stock
CHARLOTTESVILLE, Va., Feb. 18, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the…